Complex medical conditions including cancer, hepatitis, multiple sclerosis and other chronic diseases often require a specialty medication. There are several paths for processing a specialty medication and the current lack of standardization around the process means it can take days, weeks or even months to get a patient on their treatment regimen.

All stakeholders involved in specialty medications are dedicated to enabling safe and timely access to these therapies. NCPDP is focused on supporting the standardization of industry transactions for claim and service billing, predetermination of benefits, prior authorization, information reporting and ePrescribing. Through this process we gain administrative efficiencies which can improve time to initiation of therapy.

In an effort to create awareness on this topic, NCPDP’s President & CEO Lee Ann Stember wrote an article for Drug Channels website titled “Three Reasons to Join the Industry-Wide Effort to Speed Time-to-Therapy for Specialty Pharmacy”. The article can be found here.

If you would like to participate, you can work collaboratively with colleagues and competitors alike to advance health information technology solutions through NCPDP’s consensus-building process for Specialty prescriptions. Your voice impacts your business and provides value to both you and your company.

In response to market demands NCPDP created a new Work Group (WG 18) devoted to specialty.

Work Group 18 Specialty Pharmacy +

WG 18 Task Group Information +

NCPDP-Elite Partner

Covermymeds logo     Medversant logo     AmerisourceBergen        

NCPDP’s Elite Partner Program establishes the highest level of sustained support for the valuable work of NCPDP in advancing patient safety and interoperability.

For problems with the site please contact us at webmaster@ncpdp.org